Making custom CRISPR therapies could be harder than initially thoughtnews2026-04-01T19:40:47+00:00April 1st, 2026|Endpoints News|
To counter China, FDA chief wants to speed new drug trial processnews2026-04-01T19:15:42+00:00April 1st, 2026|Endpoints News|
Eli Lilly wins approval of anti-obesity pill orforglipronnews2026-04-01T15:41:36+00:00April 1st, 2026|Endpoints News|
FDA identifies eight deaths tied to Amgen’s Tavneosnews2026-03-31T19:13:11+00:00March 31st, 2026|Endpoints News|
Restore Robotics Receives FDA 510(k) Clearance for 2 Additional da Vinci Xi® Robotic Instrumentsnews2026-03-31T14:59:47+00:00March 31st, 2026|Medical Device News Magazine|
Drugmakers skeptical of new White House overtures on pricingnews2026-03-30T17:58:06+00:00March 30th, 2026|Endpoints News|
Viridian’s autoimmune eye disease shot passes Phase 3, but can it compete?news2026-03-30T15:28:50+00:00March 30th, 2026|Endpoints News|
FDA approves Novo Nordisk’s once-weekly insulinnews2026-03-27T13:43:46+00:00March 27th, 2026|Endpoints News|
Top HHS official makes impassioned pitch to take on China biotechnews2026-03-27T05:00:45+00:00March 27th, 2026|Endpoints News|
Biopharma industry pushes back on FDA’s ‘America First’ user fee proposalsnews2026-03-26T17:46:16+00:00March 26th, 2026|Endpoints News|
